The discovery of C-reactive protein (CRP) almost 80 years ago in the blood of patients with various infectious and inflammatory diseases initiated studies on the mysterious biological phenomenon called "the acute phase response" (APR). The complex metabolic alterations accompanying APR include changes in the plasma concentration of the majority of liver-produced proteins -acute phase proteins (APPs). The search for mediators released from the site of injury and able to stimulate hepatocytes led to the discovery of "Leukocytic Endogenous Mediator" (or "Endogenous Pyrogen"), initially identified with interleukin-1. Only in 1987 was the main factor able to induce the majority of symptoms of APR discovered and named interleukin-6 (IL-6). The current paradigm assumes that APR is elicited by numerous proinflammatory cytokines, the principal role being played by the IL-6-family. The last decade has brought about significant progress in understanding the initiation of the acute phase response (recognition of pathogens by Toll-like receptors), interaction of cytokines and their receptors (origin and importance of soluble cytokine receptors, construction of hypercytokines by protein fusion), the mechanism of multi-step signal transduction from the plasma membrane to nuclear transcription factors (including the role of MAP kinases), as well as elucidation of the role of receptor cross-talk in cytokine networks in health and disease. Genomic techniques indicate that hundreds of genes participate in the development of APR. The data presented here emphasize the growing importance of APR for clinical medicine and confirm the close relationship between acute phase response and innate immunity.
THE ACUTE PHASE RESPONSE AND ACUTE PHASE PROTEINS
It has long been recognized that tissue injury or invasion of pathogens elicit in the animal organism a prompt and complex, albeit unspecific, response known as acute-phase reaction (APR) that usually is followed by a delayed but highly specific immune response, both ultimately resulting in restoration of the disturbed homeostasis (for early references see [1] [2] [3] [4] ). Local response occurs in the form of inflammation whereas the metabolic changes accompanying the systemic response in mammals include leukocytosis, fever, negative nitrogen balance, decreased plasma concentration of iron and zinc, increased levels of several hormones, activation of clotting and complement pathways, and a profound rearrangement of plasma protein profile: depression of albumin and significant rise of several proteins, often containing carbohydrate chains and usually produced in liver parenchymal cells. These "trauma-inducible liver-produced plasma (glyco)proteins" [2] are regarded as acute phase proteins (APPs).
C-reactive protein (CRP), discovered in 1930 by Tillet and Francis [5] and studied first by Abernethy and Avery [6] , represents a prototype acute phase protein (for references see [7, 8] ). The protein was found in the sera of patients with various infectious and inflammatory diseases on the principle of precipitating pneumococcal C-polysaccharide. Apart from the main ligand of CRP -phosphocholine, CRP can bind to a wide variety of components such as chromatin, ribonucleoproteins, histones, fibronectin, laminin, and polycations [3, 8] . Extensive investigation carried out in several laboratories has led to characterization of the structure and function of CRP and related proteins called pentraxins (or pentaxins). The human pentraxin family includes CRP and SAP (serum amyloid P component) which share pentameric subunit structure and calcium-dependent ligand-binding capacity important for sequestration and removal of "foreign" materials from tissues. Homologues of mammalian pentraxins were found by Pepys et al. [9] in various lower vertebrates whereas Liu et al. [10] , using calcium-dependent affinity chromatography on a phosphorylcholine matrix, isolated a CRP-like protein from the haemolymph of horseshoe crab, Limulus polyphemus. This protein called limulin consists of 12 complex subunits, each containing glycosylated A and B chains associated in a double-stacked hexamer. Limulin can be regarded as an "evolutionary fossil" half a billion years old. It strongly binds bacterial lipopolysaccharide and is used in the laboratory to remove traces of endotoxin from biological preparations. All these data indicate that mammalian pentraxins are remnants of an ancient, primitive defense system operating before the advent of highly specific immunological mechanisms.
CRP occurs in the blood of healthy humans in trace amounts only but its concentration may promptly go up by several hundred fold in various inflammatory states [3] . For this reason CRP level determined by ELISA or immunonephelometric techniques is a far more sensitive indicator of ongoing pathological processes than the commonly used erythrocyte sedimentation rate (ESR) and can be employed in the clinic for the detection of incipient heart infarct or other tissue injury [8, 11] . On the other hand, SAP is constitutively expressed in man and its level does not change in inflammatory diseases although in mouse it represents a classical APP [7] . Another amyloid precursor protein known as SAA (serum amyloid A), not related structurally to SAP and studied by J.D. Sipe and her colleagues [12] , is strongly increased in the blood after injury both in man and mouse.
Taking into account changes in their plasma level and species-dependent response, acute phase proteins are divided into several classes [13] : -Spectacular APPs, increase 20-to 1000-fold: CRP (man, rabbit), SAA (man, mouse).
Strong APPs, increase 2-to 5-fold in most species, including man: fibrinogen, haptoglobin, alpha-1-acid glycoprotein, alpha-1-proteinase inhibitor.
Weak APPs, increase by 30 to 60 percent: ceruloplasmin, C3-complement.
Negative APPs, decrease by at least 20 percent: albumin, transferrin.
The APPs include some 50 plasma proteins and represent a highly heterogenous group both in respect of physicochemical properties and biological functions. They may be found among transport proteins, pathogen scavengers, proteinase inhibitors, components of the complement, coagulation and fibrinolytic pathways, and various modulators of the innate and acquired immune response [14] . The only common features of APPs are liver origin and participation in various physiological processes which tend to restore the fine homeostatic balance disturbed by the injury, tissue necrosis or infection. Since many resident proteins of liver cells also undergo quantitative changes during the acute phase response [15, 16] , some authors introduced the name "acute phase regulated intracellular proteins" or APRIPs [16] .
The molecular mechanism of induced synthesis of APPs, their variable and species-dependent responses, as well as the importance for clinical pathology, have constituted a challenge for biochemistry, molecular biology and physiology during the last 50 years. In fact, the acute phase reaction elicited in experimental animals, mainly rabbits and rats, still represents one of the working models used to elucidate the mystery of gene regulation by external stimuli. However, the last 10 years have brought significant progress in understanding the initiation of the acute phase response (recognition of pathogens by Toll-like receptors), interaction of cytokines and their receptors (origin of soluble cytokine receptors, construction of hyper-cytokines by protein fusion), as well as elucidation of the role of receptor cross-talk in cytokine networks in health and disease.
THE SEARCH FOR MEDIATORS OF THE ACUTE PHASE REACTION

Origin of Plasma APPs and Magnitude of Response
From the time of discovery of C-reactive protein until the end of the 1960s the acute phase response was regarded as a curious biological phenomenon of obscure provenance. The tissue origin of trauma-induced plasma glycoproteins remained unknown for many years; e.g., the human blood seromucoid fraction, greatly increased in inflammatory diseases, was linked to destruction of connective tissue [18] . Even the site of synthesis of CRP was disputed until Hurlimann et al. [19] demonstrated incorporation of radioactive amino acids into immunologically identified CRP after incubation of liver preparations from rabbits and monkeys subjected to inflammatory stimuli; this finding was later confirmed with cultured human hepatoma cells (for references see [20] ). The use of perfused rat liver finally demonstrated that almost all plasma proteins (except immunoglobulins) are synthesized by and secreted from hepatocytes [21, 22] . Although detailed studies showed later that some acute phase plasma proteins may be produced by extrahepatic tissues, their contribution to overall balance sheet of acute phase response is in most cases marginal [23] . At the same time measurements of absolute synthesis rates of albumin and fibrinogen by the 14 C-carbonate method of McFarlane demonstrated the unprecedented scale of changes in the output of proteins from the liver of rabbits that received intravenous injection of bacterial endotoxin [24] or subcutaneous injection of turpentine oil [25] , a known local irritant. We found [24] that 24-48 h after application of the inflammatory stimulus the synthesis of fibrinogen was increased from 54 to 230 mg/kg/day and almost reached the rate of albumin synthesis in control rabbits (334 mg/kg/day). Thus it is not surprising that many laboratories have engaged in a search for mediators released in the site of injury and able to stimulate liver parenchymal cells both in vivo and in tissue culture. With the advent of various techniques of molecular biology quantitative evaluation of the acute phase response was based on determination of acute phase proteins by immunochemical methods (such as ELISA or rocket immunoelectrophoresis), or on determination of specific mRNAs (by Northern blotting or RT-PCR) (for references see [26] ). Modern genomic analysis indicates that approximately 7% of genes in the mouse are mobilized in the hepatic APR to endotoxin [27] .
Multiple Candidates for APR Mediators
Potential stimulants of liver acute phase might include products of damaged tissues digested by lysosomal enzymes [28] , structurally modified proteins such as inactivated alpha-1-proteinase inhibitor or degradation products of fibrinogen [29, 30] , reactive oxygen and nitrogen intermediates [31, 32] , prostaglandins and other eikosanoids [33] , as well as various metabolic products of stimulated macrophages. Detailed studies proved, however, that the majority of these compounds represented just "alarm molecules" (Oppenheim et al. [34] suggested the name "alarmins"), or co-activators in the formation of highly specific messengers stimulating the liver acute phase response.
In the early 1970s at least two independent groups of investigators: S. Pekarek, R.W. Wannemacher, M.C. Powanda, W.R. Beisel and their colleagues, and R.F. Kampschmidt and co-workers drew attention to leukocytes as a possible source of mediators of liver acute phase response. They demonstrated that cells from glycogen-induced rabbit peritoneal exudates release a factor, named Leukocytic Endogenous Mediator (LEM), also known as Endogenous Pyrogen (EP), which, when injected into rats or rabbits, induced fever and leukocy-tosis, decreased serum iron and zinc, enhanced the uptake of amino acids by the liver, and stimulated the synthesis of APproteins [35] [36] [37] . The early reports were criticized due to the possibility of LEM contamination with bacterial endotoxin. Only when the Limulus amebocyte lysate test permiting the detection of bacterial lipopolysaccharide, as well as endotoxintolerant rats and endotoxin-resistant strains of mice became available, could the direct biological effects of LEM be firmly established [38, 39] .
From Leukocytic Endogenous Mediator to Proinflammatory Cytokines
By early1980s it became clear that both LEM [39] and EP [40] represent not a single molecular species but rather a family of low molecular weight proteins. At the same time Hanson et al. [41] demonstrated that in the peritoneal exudate macrophages, and not neutrophils, are the main source of LEM/EP. Other authors reported that macrophages deriving from peripheral blood mononuclear cells and cultured in vitro produce not only mediators of the LEM/EP type stimulating synthesis of APPs but also release other regulatory proteins called collectively interleukins, lymphokines or cytokines, all affecting the immune response [42] [43] [44] . In the light of this evidence the Second International Lymphokine Workshop held at Ermatingen (Switzerland) proposed the name interleukin 1 (IL-1) for "a macrophage-derived, hormone-like factor of 12-16 kDa that has a multiplicity of pleomorphic amplifying effects on immunological and inflammatory reactions".
The interleukin-1 era, when literally hundreds of papers were published claiming IL-1 responsible for almost all features of inflammation, immune reaction or liver acute phase response, lasted for a few years (the period around 1982-87). However, experimental results coming from various biochemical laboratories demonstrated that purified or recombinant preparations of IL-1 cannot elicit typical APR in cultured rat or mouse hepatocytes, and the active fraction produced by stimulated macrophages or cancer cells, named hepatocyte-stimulating factor (HSF), differs from IL-1 in respect of molecular parameters [45] [46] [47] . The final breakthrough in this controversy came in May 1987 at the Cold Spring Harbor Symposium with the report of Jack Gauldie and his colleagues who demonstrated that HSF was identical with interferon 2 / B-cell stimulatory factor 2, also known as hybridoma/plasmocytoma growth factor, 26-kDa protein, interleukin HP1, monocyte-granulocyte inducer type 2, or interleukin-6 (IL-6) [48] . The name interleukin-6 for the principal acute phase cytokine was finally accepted at the NYAS conference on December 14, 1988 in New York [49, 50] . Multiple initial names of IL-6 justly reflect a broad and diverse effects exerted by this cytokine in vivo (for references see [51, 52] ). In the following years the research on IL-6 and related cytokines accelerated considerably and at the next NYAS cytokine meeting (organized by A. Mackiewicz, A. Koj and P. Sehgal in Poznan in 1994), a broader title: "Interleukin-6-type cytokines" had to be used [53] .
CYTOKINES: MORE THAN REGULATORS OF THE IMMUNE RESPONSE
How Many Cytokine Species Do Really Exist ?
The name "interleukin", implying communication between various types of leukocytes, is in many cases misleading and biochemists prefer the more broad term "cytokine" which includes various traditional groups of tissue-produced regulators. As Charles Dinarello concludes in his recent historical review [54] :
"Today, the term cytokine encompasses interferons, the interleukins, the chemokine family, mesenchymal growth factors, the tumour necrosis factor family and adipokines".
Taking into account properties of the cytokines and their receptors Debets and Savelkoul [55] divided in 1996 majority of the then known cytokines into six classes (and some subclasses) with typical examples reported for each class ( Table 1) . Up to now over 30 interleukins have been described [56] , and not all of them fit into Debets and Savelkoul's scheme. Moreover, new cytokine families have been identified, such as adipokines produced by adipose tissue and including leptin, adiponectin, resistin and visfatin [57] . In addition, the classification shown in Table 1 does not provide information about biological function of cytokines. For these reasons cytokines important for the acute phase response are often divided into pro-inflammatory (e.g. IL-1, IL-18, TNF , IFN , IL-8, IL-12), and anti-inflammatory ones (e.g., IL-4, IL-10, IL-13, IFN , TGF ), with the IL-6-family standing apart since their functions in the process of inflammation are ambivalent and to some extent depend on the phase of the response [29] . Since majority of cytokines show the whole spectrum of biological effects it is very difficult to establish the total number of cytokines participating in a given pathological event. Moreover, the list of cytokines is still open and a new cytokine is being described almost every year (for references see [58] ).
Some pro-inflammatory cytokines (e.g. IL-1 or IL-18) are produced as precursors and for secretion must be processed by specific proteases identified as converting enzyme [59] or caspase-1 [60] . The processing occurs in specialized protein platforms referred to as inflammasomes [61, 62] . Recent studies suggest that release of mature IL-1 from inflammasome requires ATP and the P2X 7 receptor [63] . Caspase-1 also participates in the processing of interferon regulatory factor and thus in the induction of IFN by endotoxin [64] . Since some caspases are involved in apoptosis we now understand better the role of cytokines in cell death and survival under inflammatory conditions.
Specific Properties of Cytokines and their Role in Health and Disease
Evaluation of the role of individual cytokines in various events of the acute phase response is additionally complicated by the common occurrence of pleiotropy (multiple biological activities of a cytokine) and redundancy (overlapping activities of various cytokines). These phenomena have been explained by the structure of plasma membrane receptors and various components of intracellular signaling pathways [51, 65, 66] . The best known example of pleiotropy and redundancy shown in Fig. (1) is provided by the IL-6 family [52] .
Ozaki and Leonard [51] listed several cytokines sharing signaling components of the receptor complexes such as: IL-3, IL-5, GM-CSF (common -chain); IL-6, IL-11, LIF, OSM, CNTF, CT-1 (common gp130); IL-2, IL-4, IL-7, IL-9, IL-15, IL-21 (common -chain). The overlapping activities of members of the IL-6 family appear to represent a typical feature of the whole class of low molecular weight regulatory proteins that emerged during a long process of evolution of tissue differentiation and immune response in the animal kingdom.
The described phenomena of pleiotropy and redundancy suggest that the cytokine system has a high survival value: loss of a gene coding for one of the cytokines from IL-6 family can be (at least in some respects) compensated for by other members of this cytokine family. It has been reported that knock-out mice deficient in IL-1 or IL-6 do not develop acute phase response induced by a local irritant, such as subcutaneous injection of turpentine, but can mount a Fig. (1) . Scheme of molecular basis of cytokine pleiotropy (A) and redundancy (B). Receptors recognizing cytokines from the IL-6 family are composed of multiple subunits, one of them being cytokine specific and the other is always gp130 able to generate the intracellular signal after dimerization (not shown here for the sake of clarity). Thus a single cytokine may elicit various effects depending on target cells (A) due to cell-specific metabolic responses (marked here as variously shaped blocks associated with the cytoplasmic tail of gp130). On the other hand, receptors of various cytokines from the IL-6 family share the gp130 subunit and they elicit identical response in a given target cell (B). typical response when stimulated by i.p. injection of LPS [67] [68] [69] [70] . These observations permit one to conclude that in LPS-induced systemic response other cytokines from the IL-6 family replace the missing IL-6, LIF being the most likely candidate [69] .
The molecular basis underlying the functional pleiotropy of cytokines has been analyzed by Hirano [71] who discussed two models: receptor conversion model (a mechanism generating functional diversity of a cytokine), and orchestrating model (simultaneous generation of contradictory signals through a receptor in a given target cell).
Many cytokines are able to react not only with the membrane-bound receptor but also with its soluble form containing functional extracellular domains. Such soluble receptors are produced either by translation of an alternatively spliced receptor mRNA, or by proteolytic cleavage of the membrane-bound receptor -the process known as receptor shedding [72, 73] . The soluble forms of receptors compete for free cytokines with the plasma membrane receptors and thus behave as inhibitors or biological antagonists, sometimes as cytokine scavengers or carriers. TNF has two distinct shedding-derived soluble receptors that bind this cytokine with high affinity. Their potential therapeutic application in inflammatory diseases is hampered by the fact that TNF in a complex with the soluble receptor shows prolonged half-life in vivo [74] . In the case of IL-1 the situation is complicated: out of two receptors only one (IL-1RI) reacts with the cytokine and generates a signal whereas the second one (IL-1RII) is a "decoy receptor" deficient in signal generation. The IL-1 system is, however, unique in having a special inhibitory molecule -the IL-1 receptor antagonist (IL-1Ra). As reported by Dinarello [75] both IL-1RII and IL-1Ra show lower affinity for IL-1 than IL-1RI, and therefore their usefulness as blockers of IL-1-induced inflammatory reactions is rather limited.
The receptors of IL-6 and other cytokines of this family share the membrane receptor subunit generating signal (gp130) and their soluble forms behave as agonists [72, 76] . In in vivo experiments the IL-6/sIL-6R complex binds to the membrane-anchored gp130 subunit present in several types of cells unresponsive to free IL-6 since they do not express the membrane-bound IL-6R. This phenomenon named transsignaling is responsible for much broader biological effects of IL-6 than those predicted from the occurrence of cellular membrane-bound receptors. Recent studies indicate that trans-signaling induced by IL-6/sIL-6R can be efficiently inhibited by a soluble form of gp130 obtained by recombinant technique or differential splicing [76, 77] . According to Rose-John et al. [76] and Mitsuyama et al. [78] , the IL-6-dependent trans-signaling is involved in transition from acute to chronic inflammation, as well as in transition from innate to acquired immunological response [79] . This is achieved by modulation of leukocyte recruitment and activation, usually followed by apoptotic clearance of individual leukocyte subpopulations, as well as by modulation of signal transduction: STAT3 phosphorylation and production of a suppressor of cytokine signaling (SOCS3) (for references see [78] ).
The various effects of an interaction of IL-6 with the membrane-bound and soluble IL-6 receptors prompted RoseJohn to develop designer cytokines which could specifically enhance or inhibit IL-6 trans-signaling. One of them, Hyper-IL-6, was created by fusion of the carboxy terminus of sIL-6R with the amino terminus of IL-6 by a flexible peptide linker (for references see [80, 81] ). A fusion protein of IL-11 and soluble IL-11 receptor [82] acts as a superagonist on cells expressing gp130. The designer cytokines have been found useful in therapeutic applications such as long-term culture of stem cells, liver regeneration and inhibition of certain forms of chronic inflammation [81] .
Cytokines were initially regarded as locally acting proteins involved in inflammation, immunological response and differentiation of certain types of cells. The picture which emerges now -some 25 years after the discovery of IL-1 and 20 years after identification of IL-6 as the main regulator of APR -is quite different. Today cytokines stand as a separate class of regulators, probably equivalent to hormones in respect of biological importance. They affect almost all physiological processes, starting from embryo implantation, some stages of embryogenesis, tissue differentiation, proliferation and maturation of various blood cells, innate and acquired immune responses, bone reconstruction or neural cell differentiation. Moreover, they are key players in several pathological processes such as inflammation, acute phase response, septic shock syndrome, allergic reactions and cancerogenesis. They may decide about cell survival or apoptotic death. The highly complex network of cytokines maintains our health or modifies the course of disease.
A LONG WAY FROM PLASMA MEMBRANE RE-CEPTORS TO NUCLEAR GENES AND THEIR PRODUCTS
Intracellular Signaling Cascades Important for Cytokines
Plasma membrane receptors of mammalian cells recognizing protein ligands such as hormones or cytokines belong to several structural classes and are often composed of multiple subunits [55, 83, 84] . In all cases, however, the receptor extracellular domain binds the ligand while the cytosolic domain mobilizes various proteins participating in signal transmission to the nucleus, thus coupling the stimulated receptor with specific transcription factor or factors. The signal is propagated by consecutive recruitment and phosphorylation of target proteins either on Ser/Thr or Tyr residues, the latter being recognized by SH2 domains.
The common pathways used by cytokines include receptors linked to the NF-kappaB pathway (TNF and IL-1 families), receptors with intrinsic tyrosine kinase activity (insulin, EGF, VEGF, PDGF, FGF), receptors recruiting intracellular tyrosine kinases, such as the JAK/STAT pathway (the majority of cytokines, including families of IL-6 and interferons), TGF receptors utilizing SMAD proteins, and chemokine receptors using G proteins. For the acute phase response two signal transduction cascades are the most important: one using the NF-B activation pathway and the other the JAK/STAT pathway ( Table 2) .
In 1986 Sen and Baltimore described a nuclear factor (NF-kappaB) activating the expression of some immunoglobulin genes but it soon became clear that NF-B functions as a pleiotropic mediator of inducible and tissue-specific genes, especially those participating in inflammation, cell differentiation and apoptosis [87] [88] [89] [90] . The DNA-binding nuclear form of NF-B is usually a heterodimer of p50/p65 subunits belonging to the Rel family comprising five isoforms. In non-stimulated cells NF-B dimers are sequestrated in the cytosol bound to the inhibitory protein I B, which can be removed by dual Ser phosphorylation followed by ubiquitination and degradation in the proteasome. The major protein kinases activating NF-B complexes are known as NIK (NF-kappaB inducing kinase) and IKKs (I B kinases and ). IKKs require additional regulatory or scaffolding proteins such as IKK and NEMO (NF-B Essential Modulator); in effect, high molecular weight complexes are formed known as signalosomes.
The list of adaptor proteins and kinases participating in NF-B activation is much longer than those shown in Table  2 and Fig. (2) . This broad array of adaptors and kinases provides a molecular basis for modification of the NF-B cascade depending on various signals. The variable routes used by the NF-B pathway are well documented at the stage of MAP kinases [91] . MAP kinases, activated by dual phosphorylation on Tyr and Thr/Ser, are usually grouped into three major classes: ERKs (Extracellularly Regulated Kinases), JNKs (c-Jun N-terminal Kinases), the latter also known as SAPKs (Stress-Activated Protein Kinases), and p38 MAP kinases occurring in at least four isoforms [92] [93] [94] . ERKs regulate multiple targets in response to PMA (phorbol mirystoyl acetate) or cellular growth factors (such as EGF) with the involvement of a Ras-dependent mechanism, whereas JNKs/SAPKs and p38 activate transcription factors c-Jun or STAT in response to pro-inflammatory cytokines and growth factors [95] , or exposure of cells to environmental stress such as osmotic shock [96] [97] [98] or hypoxia [99, 100] . Thus SAPKs and p38 may be regarded as intracellular sensors initiating a chain of reactions in complementation to the receptor-induced response. MAP kinase signaling can activate not only NF-B but also other transcription factors such as AP-1 or Elk-1 (see below).
However, the role of MAP kinases in the regulation of acute phase reaction is even broader since the p38 MAP kinase affects the stability of cytokine mRNAs. It is well established that mRNAs coding for short-lived proteins, such as IL-1, TNF , IL-6 or IL-8, contain in the 3' untranslated region (3'UTR) AU-rich elements (AREs) recognized by specific RNases and promptly degraded [101, 102] . The ARE sequences can be protected or exposed to degradation by binding regulatory proteins such as CSAIDS (cytokinesuppressive anti-inflammatory drug-binding proteins), KSRP, HuR or TIAR, as well as TTP (Tristetraproline protein) [103] [104] [105] . Inhibition of p38 MAP kinase by some pyridynilimidazoles, such as SB203580, reduces the stability of mRNA coding for TNF and IL-1 at the translational level, and IL-6 production also at the transcriptional level (for references see [106, 107] ). Holtmann and associates have demonstrated that IL-1-induced IL-8 synthesis is upregulated by the SAPK/JNK pathway which synergizes with the NF-B pathway, whereas p38 MAP kinase increases stability of the IL-8 transcript [91, 108] .
The signaling pathway utilized by IL-6 was unknown until 1993 when a group led by Friedemann Horn in the laboratory of Peter Heinrich isolated a nuclear factor rapidly activated by IL-6 and binding to acute phase response elements in the promoters of APP genes [109] . This acute phase response factor (APRF) was later found to be identical with STAT3 (signal transducer and activator of transcription) belonging to STAT family of transcription factors investigated by Darnell [110] who discovered that STAT1 is predominantly used by interferons. We know today that STAT3 is used by the entire IL-6 and IL-10 families, as well as by G-CSF, leptin, IL-21 and IL-27 (for references see [111] ).
Studies carried out in many laboratories have led to the conclusion that binding of IL-6 to its plasma membrane receptor results in dimerization of gp130 followed by mobilization of protein tyrosine kinases from the JAK (or TYK) families that phosphorylate specific Tyr residues in the cytoplasmic tail of gp130. These residues are recognized by STAT3 monomers which then undergo phosphorylation, dimerization and transfer to the nucleus where they interact with promoter regions of genes coding for almost all APPs (for references see [112] [113] [114] ). This paradigm has recently been challenged by a team of Pravin Sehgal who demonstrated that STATs may occur in the cytosol in the form of high-molecular weight complexes (statosomes); moreover, these authors reported that plasma membrane domains ("rafts") participate in STAT activation, and that activated STATs are targeted to sequestering endosomes [115, 116] . Some controversy in the JAK/STAT pathway is also related to the functional equivalence of various JAK/STAT combinations, to differences in the mechanism of activation among the members of IL-6-family and anti-inflammatory cytokines such as IL-10, and finally, to the negative regulation of this signaling pathway by SOCS (suppressors of cytokine signaling) (reviewed recently by Murray [117] ).
Role of Various Families of Transcription Factors in Cytokine Gene Expression
Genes coding for the majority of cytokines have been cloned and sequenced; a striking feature of their promoter regions is the occurrence of binding sites for a variety of transcription factors (for references see [17, 106, 118] ). However, out of some 2000 known transcription factors binding sequences [84, 106, 119] , the most often found in cytokine promoters are sequences binding NF-B, STAT, C/EBP (CAAT enhancer-binding protein), AP-1 (activator protein-1), CBP (cAMP-responsive element-binding protein) and Elk-1. In effect, a multiprotein complex responsible for effective gene transcription, called enhanceosome, is usually formed [85, 118] . The role and mechanism of action of NF-B and STATs have been briefly discussed above; the C/EBP family includes seven members sharing such structural features as a C-terminal leucine zipper, a basic DNA-binding region, and an N-terminal trans-activating region. The most important for acute phase reaction are C/EBPbeta and delta (synonym: NF-IL6) enhancing the expression of genes coding for macrophage cytokines or liver APPs [120] . The importance of C/EBP family members in the induction of IL-6 and the role of tumor suppressor protein p53 were studied by Sehgal and co-workers [53] . Leucine zipper is also a prominent feature of activator protein-1 (AP-1) which occurs as either a c-Jun homodimer, or (more often) as a c-Fos/c-Jun heterodimer engaged primarily in the regulation of expression of growth factors, cytokines and acute phase proteins [121] . Elk-1 contains an Ets domain and serves as an integration point for different MAP kinase pathways; it binds and activates serum response elements in the promoters of target genes (like c-fos) in a ternary complex with another transcription factor, serum response factor. All Ets proteins function as critical nuclear regulators of ubiquitous signaling cascades involved in cell proliferation, differentiation and oncogenic transformation [122, 123] .
The interactions among the numerous transcription factors competing for binding sites in the promoter regions of various genes are highly complex, and the regulation of IL-6 expression described in detail first by Sehgal et al. [53] and later by Van den Berghe et al. [85, 118] may serve as an example. After binding to specific DNA sequences transcription factors recruit enzymic partners with activities of acetyltransferases, deacetylases, methyltransferases and various kinases which modify chromatin structure and enable to assembly large multiprotein complexes competent in transcription (enhanceosomes). They contain not only the transcription factors: AP-1, CREB, C/EBP or NF-B but also proteins functioning as integrators and transactivators. The multiple steps in the regulation of transcription factor activity are thoroughly discussed in [124] .
On the other hand, activation of STAT3 leads to the expression of not only many genes coding for APPs but also of SOCS3 which binds to and inhibits the kinase activity of JAK associated with gp130 [125, 126] . This represents a typical loop of feedback inhibition. However, SOCS3 expression is also stimulated by TNF which enhances SOCS3 mRNA stability through activation of p38 MAP kinase [127] .
Receptor Cross-Talk and Cytokine Networks
The final outcome of cell stimulation by one of the many signaling pathways depends on the mutual interactions between these pathways, interactions known as receptor crosstalk. The communication between the IL-1-induced NF-B pathway and IL-6-induced STAT3 pathway may serve as a good example of this phenomenon. In early studies, after a clear distinction between IL-1 and IL-6 had been made, many authors reported inhibitory effects of IL-1 or TNF on the synthesis of certain acute phase proteins, such as fibrinogen [128, 129] , whereas a synergism of IL-1 and IL-6 was observed in the induced production of serum amyloid A protein [130] . Those reports permitted Heinz Baumann and Jack Gauldie [131] to divide cytokines and APPs into two separate groups: type 1 cytokines (IL-1 and TNF families) stimulated synthesis of type 1 APPs (CRP, SAA, complement C3, alpha-1-acid glycoprotein) and synergized with type 2 cytokines (IL-6 family), whereas type 2 APPs (fibrinogen, human haptoglobin or rat alpha-2-macroglobulin) were stimulated by type 2 cytokines (IL-6-family) but inhibited by IL-1 or TNF . The balance between the pathways of type 1 and type 2 cytokines was found to be very delicatethe magnitude of synergistic activation of SAA promoter by IL-1 and IL-6 depended on the order of cytokine addition [132] . Cha-Molstad and co-workers [133] in Kushner's laboratory in Cleveland found that C/EBPbeta was involved in the synergistic effects of IL-1 and IL-6 during the induced synthesis of CRP. Current explanation of the synergistic mechanism of cytokine-induced CRP synthesis in human hepatoma Hep3B cells assumes formation of a complex composed of c-Fos/STAT3/HNF-1 [134] .
Zhang and Fuller [135] offered a simple mechanistic explanation of the cross-talk between the NF-B and STAT3 pathways: a direct competition of these transcription factors for binding sites located next to each other in the promoter regions of the APP genes. However, this cannot be the only explanation as indicated by experiments on the inhibition of the STAT pathway by MAP kinases [136] , or modulation of the IL-1-mediated inhibition of STAT3 by IL-4 and redox state [137] . Also a cross-talk between STAT3 and estrogen receptor has been reported to inhibit the STAT pathway [138] .
There is no doubt that the numerous signaling pathways initiated by cytokines interact with one another and create a complex cytokine network. As emphasized by Heinrich and co-workers [113] , the additional complexity arises from the fact that the cross-talk between signaling pathways depends on the cell type and stage of differentiation. We observed that three anti-inflammatory cytokines (IL-4, IL-10, IL-13) inhibit LPS-induced expression of IL-6 in haematopoietic cells, but two of them (IL-4 and IL-13) give opposite effects in other cell types derived either from the endothelium (HUVEC), or from the liver (HepG2). When HUVEC and HepG2 were cultured together and stimulated with LPS the IL-6-dependent synthesis of haptoglobin was decreased in the presence of IL-4 or IL-13 indicating that in the co-culture the inhibitory effects of these cytokines on HepG2 cells prevail over stimulation of IL-6 synthesis in HUVEC cells [139] .
The cytokine network is often depicted as multiple arrows inside a cell, or between different cells, the picture depending to a considerable extent on the fantasy of the author. One can envisage, however, that with advancing understanding of chemical parameters of signaling pathways an adequate mathematical model of such a network will emerge eventually.
TOLL-LIKE RECEPTORS AS NOVEL IMPOR-TANT PLAYERS IN THE INITIATION OF ACUTE PHASE RESPONSE
Discovery of Toll-Like Receptors and their Function
By early 1990s it was generally accepted that NF-B is the main transcription factor involved in immune responses, being strongly activated by both bacterial endotoxin and proinflammatory cytokines such as IL-1 or TNF [140] . The search for other possible ligands activating the NF-B pathway has led to a surprising discovery of a new class of plasma membrane receptors present on macrophages and other mammalian cells: receptors able to discriminate between self and non-self by recognizing pathogen-associated molecular patterns (PAMPs) typical for certain groups of pathogens. Classic examples of PAMPS are mannans from the yeast cell wall, peptidoglycan components of the bacterial wall, bacterial DNA containing nonmethylated CpG sequences, as well as viral double-stranded RNA. Structural analysis of these receptors led to an unexpected findingthey all shared considerable similarity with proteins described earlier in Drosophila melanogaster where they had a double function: control of embryonal development and protection against invading fungi and bacteria. Those Drosophila proteins had been known as "toll receptors" so their mammalian counterparts were promptly named "Toll-like receptors", or TLRs [141] .
TLRs play a critical role in the initiation of innate immune response against invading pathogens [142] . More than ten TLRs, differing in structure, ligand affinity and intracellular signal transduction pathways they activate, are known.
In mammals TLR-4 signals the presence of bacterial lipopolysaccharide (endotoxin) by associating with CD14, the macrophage receptor for LPS. At first LPS is bound by the soluble liver-produced acute phase LPS-binding protein (LBP). The resulting LPS-LBP complex is recognized and bound by a glycolipid-linked membrane protein CD14. Both LBP and CD14 have characteristic leucine-rich repeat motifs required for their functioning. The LPS-LBP-CD14 complex interacts with a transmembrane Toll-like receptor TLR-4 resulting in generation of an intracellular signal (Fig. 2) . Certain data indicate the importance of another protein, MD-2, required for the interaction of LPS-LBP-CD14 with TLR-4 [143] . It was found that mice with mutated TLR-4 gene were genetically unresponsive to LPS from Gram-negative bacteria and did not suffer from septic shock although they remained highly sensitive to Salmonella typhimurium, a natural pathogen of mice [144] .
Another mammalian Toll-like receptor, TLR-2, is stimulated by binding proteoglycans of Gram-positive bacteria, whereas TLR-3 recognizes double-stranded RNA, TLR5 -bacterial flagellin and TLR9 -CpG-containing DNA (for references see [144, 145] ). However, specificity of Toll-like receptors is still being disputed, especially in the light of possible combinatorial repertoire of TLRs subunits which form active dimers [146] . To commonly occurring heterodimers belong TLR1/2 and TLR2/6. Some typical ligands of mammalian TLRs are listed in Table 3 . 
Adaptor Proteins in Toll-Like Receptor Signaling
The Toll signaling pathway in adult flies involves four signaling proteins (Pelle, Tube, Cactus, Dif) and directly induces production of antimicrobial peptides such as drosomycin [142] . In mammals TLR signaling starts with a family of five adaptor proteins coupling the downstream protein kinases that ultimately lead to the activation of transcription factors such as NF-B (Fig. 2) , or interferon regulatory factors (IRFs) [147] . Only then are promoter regions of certain genes containing NF-B-binding sequences, or IRF-binding sequences, activated. This leads to the synthesis and secretion of cytokines (such as IL-1, TNF and IL-6), chemokines (such as IL-8) and type I interferons, all of them participating in the acute phase reaction and in the initial stages of acquired immunological response. The Toll signaling in mammals results also in the production of co-stimulatory molecules, such as CD86, engaged in the adaptive immune reactions.
Among nine mammalian Interferon Regulatory Factors at least two (IRF-3 and IRF-7), regarded as early IRFs, are activated by Toll-like receptors [148] . Upon activation they are phosphorylated by IkappaB kinase and after dimerization are translocated into the nucleus to stimulate the synthesis of interferon alpha or beta. These interferons in turn use the JAK/STAT pathway to induce synthesis of specific proteins involved in defense against viral infection [149] .
The five mammalian adaptor proteins (MyD88, MAL, TRIF, TRAM and SARM) involved in signal transduction from Toll-like receptors to responsive genes show considerable structural differences but they all contain a motif known as a Toll/Interleukin-1-receptor (or TIR) domain localized at the C-terminal end of the polypeptide [150] . The TIR domain is a stretch of approximately 160 amino acid residues arranged in five beta sheets connected by flexible loops. Upon ligand binding to a TLR receptor the TIR domains dimerize forming a structural platform for cytosolic signal transduction [151] . The importance of the TIR domain was first discovered in the signaling by the type 1 IL-1 receptor and the adaptor named MyD88, since this protein was induced during terminal differentiation of myeloid precursors in response to IL-6. MyD88-deficient mice were shown to be unresponsive to the majority of TLRs ligands but also impaired in their response to IL-1 and IL-18 (for references see [147] ). MyD downstream signaling outlined in Fig. (2) exists in several alternative pathways leading to activation of numerous transcription factors such as NF-B, AP-1, ELK and IRFs, which are responsible for a variety of biological effects [140, 147] . As emphasized by Akira [150] , the TLR4-mediated response to LPS may involve both MyD88-dependent and -independent pathways, each of them leading to the activation of MAP kinases and NF-B.
The second adaptor of the TIR-domain family, called MAL (MyD88-adaptor-like protein) contains a phosphatidylinositol-4,5-bisphosphate binding motif and is required for signaling by TLR-2 and TLR-4, serving as a bridge to bind MyD88. MAL has also a TRAF6-binding domain recruiting this protein into a signaling complex. Khor et al. [151] have recently reported that a human variant of MAL (Ser180Leu) is involved in the increased resistance to malaria, tuberculosis and pneumococcal pneumonia. This variant shows impaired recruitment of MAL to TLR-2 resulting in decreased stimulation of TLR-2, which in heterozygotes is sufficient for host defense without over-production of cytokines and fully developed manifestations of disease [147] .
TRIF is an adaptor protein which interacts with TLR-3 and is mainly responsible for induced production of interferon beta with the engagement of IRFs. Simultaneous stimulation of NF-B leads to increased output of proinflammatory cytokines and increased response to apoptotic stimuli. TRIF is regarded as the principal TIR-family member engaged in regulation of apoptosis. Signaling through TLR-3 is short-lived since the interaction of TRIF with TLR-3 is gradually reduced by SARM (for references see [147] ).
TRAM functions in cooperation with TLR-4 and is required for induction of IL-6 or TNF . Its regulation by PKC is as yet not fully understood.
The last of the five adaptors, SARM, has its orthologue in Caenorhabditis elegans. As shown by Couillault et al. [152] and Liberati et al. [153] human SARM is a negative regulator of NF-B and IRF activation by blocking the TRIF pathway. In the absence of SARM expression, viral RNA and LPS were more active in the induction of cytokines and chemokines. Thus SARM provides a negative feedback regulation of TLRs signaling pathway. In certain aspects SARM function resembles SOCS3 in the JAK/STAT cascade.
Various Non-Canonical Functions of Toll-Like Receptors
Recent studies suggest that Toll-like receptors not only control the innate immune responses and are involved in the initiation of acute phase reaction, but also provide an interface between innate and adaptive immunity [154] . Moreover, their role is broader than sensors initiating the response to invading pathogens. Larsen et al. [155] found that TLRs expressed in cells of the CNS participate not only in response to injury but also are important for brain development. The cross-talk between various TLRs allows for modification of responses to some ligands: e.g., TLR4 engaged in endotoxin detection is often down-regulated by treatment with ligands other than LPS [156] . Genetic polymorphism of TLRs is a new fascinating subject of studies of as yet unknown potential: as reported by Pabst et al. [157] polymorphism of TLR-4 (Asp299Gly and Thr399Ile) is associated with chronic form of sarcoidosis. Toll-like receptors 7, 8 and 9 are expressed not only on the cell surface but also in the endosomal compartment and link innate immunity to autoimmunity [158] . Thus endosomal TLRs may face an extra challenge to induce anti-pathogen immune responses while avoiding the induction of autoimmune diseases. This bimodal TLRs distribution is also important in fighting viral infections: TLRs 3, 7, 8 and 9 recognize viral components both at the cell surface and on endosomal membranes, thus in a different stage of viral infection [159] .
Most recently, Kleinman and co-workers [160] drew attention to a strange relationship between suppression of angiogenesis by siRNA and the role of TLR-3. Small interfering RNA is highly specific but in the case of blood vessel growth inhibition it appears to act generically, and even without entering the cell. While this complex relationships between TLR-3 and angiogenesis require additional studies, much more is known about the links between TLRs and heme oxygenase-1 (HO-1), one of the key enzymes participating in the process of inflammation and vascular pathobiology [161] . Shen et al. [162] suggest that HO-1 modulates the inflammatory responses triggered by TLR-4. Although heme is a potent activator of TLR-4 and acts as an extracellular signaling molecule affecting cellular functions through a receptor-mediated mechanism [163] , carbon monoxide, a product of HO-1-catalyzed heme degradation, has antiinflammatory properties due to inhibition of signaling via TLRs 2, 4, 5 and 9 (but not that via TLR-3), by affecting translocation of TLR-4 to lipid rafts [164, 165] .
CURRENT VIEWS ON THE MOLECULAR MECHANISMS OF ACUTE PHASE REACTION
Double Cytokine Cascades in the Development of Acute Phase Response
The evidence reviewed above permits one to draw a cascade of events starting from the site of local injury and leading to systemic acute phase response (Fig. 3) . The role of "sensors" in pathogen-free tissue injury (resulting from osmotic shock, hypoxia, accumulation of free radicals etc) is generally played by certain MAP kinases, although hypoxia may activate specific proline hydroxylases that modify hypoxia-inducible factor (HIF-1) [168] . HIF-1 in turn stimulates the expression of vascular endothelial growth factor (VEGF) responsible for the formation of blood vessels. Usually, however, the multi-step cascade of MAP kinases activated by the pathogen-free injury merges at some point with the cascade initiated by Toll-like receptors and adaptor proteins resulting in the activation of transcription factors, among which the dominant role is played by NF-B. Macrophages represent the first line of defense and respond promptly to these signals by switching on the synthesis of pro-inflammatory cytokines: IL-1 and TNF families. Similar properties are exhibited by other types of cells exposed to the contact with the external world, such as keratinocytes and epithelial cells.
The release of cytokines to the circulating blood initiates the second cytokine cascade leading to full symptoms of systemic acute phase response: fever, leukocytosis, activation of complement and synthesis of APPs in the liver (Fig.  3) If the invasion of pathogens is not stopped and they spread in the organism, septic shock may appear leading to a fatal outcome. This is caused not only by the harmful effects of the pathogens but also by overproduction of proinflammatory cytokines, especially TNF and chemokines, that are responsible for the multiorgan failure (reviewed in [170] [171] [172] ). The two consecutive cascades of events depicted in Fig. (3) represent a simplified picture. In reality, the course of acute phase response depends on many factors not listed here, and recent evidence indicates that hundreds of genes of various function participate in the fine tuning of APR.
Global Changes in Cytokine-Modulated Gene Expression Profile of Various Cells
Although genes coding for acute phase plasma proteins produced in liver are well characterized, relatively little is known about changes in the complete transcriptome induced by cytokines in hepatocytes and other cells. Advances in genomics have provided novel techniques, such as subtractive hybridization, differential display or microarrays (for references see [173] ), enabling to meet this challenge. Already in 1999 Olivier and co-workers [15] from the laboratory of J.P. Salier used differential screening of arrayed cDNA clones and found in rats injected with Freund's adjuvant a novel set of hepatic mRNAs coding for mostly intracellular proteins. More recently the Salier's group studied changes of the human liver transcriptome in patients with acute systemic inflammation [174] . They found over 150 specific mRNAs expressed in the liver and correlating with the extent of inflammatory processes. This number was increased to over 600 genes in a model system of cultured Hep3B cells exposed to a conditioned medium of LPSstimulated macrophages [175] . The authors evaluated contribution of transcription rates, stability of mRNAs and translation efficiency to the overall effect representing the acute phase response. According to Coulouarn et al. [175] , the induced mRNAs appeared in the cell in consecutive transcriptional waves corresponding to functionally related proteins produced in an orderly fashion.
Recently we employed differential display analysis in a relatively simple model: HepG2 cells stimulated with low doses of IL-1 or/and IL-6 [16] . Out of 88 cDNA species modulated by IL-6 only 38 represented various known genes, 18 clones matched genomic clones in the NCBI data Fig. (3) . Two consecutive cascades initiating the acute phase response: from sterile tissue injury or invasion of pathogens to cytokine formation (primary response, occurs within 4 h), and from cytokine release to the synthesis and accumulation in the blood of acute phase proteins (secondary response, developed during subsequent 20 h).
with hypothetical cDNA sequences and the remaining 32 clones showed no homology with databases. In the experiments with HepG2 cells stimulated with the mixture of IL-1 and IL-6 only 43 cDNA fragments were amplified suggesting negative regulation by IL-1. The identified transcripts modulated by IL-6 alone, or by both cytokines, were found to code for intracellular proteins engaged in metabolism, protein synthesizing machinery and cellular signaling.
Since macrophages are also crucial for the development of acute phase response, several attempts have been made to identify pathogen-induced changes in the transcriptome using microarrays [176, 177] . Many induced genes were found to code for receptors, signal transduction relays and transcription factors. Although some pathogen-specific signatures of transcriptome were detected, the picture is highly complex and requires further studies. We have recently identified IL-1-and IL-6-responsive genes in human monocytederived macrophages using Affymetrix microarray [178] . Out of 4886 probe sets consistently detected in all array replicates we found over 200 genes modulated by IL-1 and/or IL-6, among which 34 could be regarded as novel cytokine-responsive genes of various functions. A detailed analysis indicated that 125 transcripts were stimulated by IL-1 and 39 by IL-6, whereas the number of down-regulated genes was similar for both cytokines (approximately 30 genes in each group). One has to remember, however, that microarray results are difficult to interpret and are not always reproducible, especially for macrophages derived from various blood donors.
SOME CLINICAL ASPECTS OF ACUTE PHASE RESPONSE
Various symptoms and features of APR are used in clinical diagnosis, prognosis and monitoring treatment effectiveness. Jacques Bienvenue and colleagues [170] recommend determination of specific cytokines in plasma and body fluids in the course of acute inflammation and septic shock, progression of cancer and in the post-transplantation period. As mentioned earlier, Devaraj et al. [11] were able to define a pro-inflammatory phenotype using blood CRP level as the biomarker.
In principle, the acute phase response is a positive phenomenon and does not require medical intervention, except in two cases:
dramatic overproduction of pro-inflammatory cytokines leading to septic shock syndrome, or, -protracted action of pathogens and protracted release of pro-inflammatory cytokines, often accompanied by defects in acquired immunological reaction, leading to chronic inflammatory diseases, such as rheumatoid arthritis.
In both cases inhibition of cytokine synthesis may be a remedy but the dramatic speed of septic shock development requires immediate treatment that is not always available [171] . The majority of typical anti-inflammatory drugs, such as glucocorticoids or salicylates, inhibit cytokine synthesis or availability. According to Allison and co-workers [179] glucocorticoids decrease the stability of cytokine mRNA whereas De Bosscher, vanden Berghe and Haegeman [180] , and Pfeilschifter and Muehl [171] emphasize the importance of a direct interplay of glucocorticoid receptor and transcription factors NF-B and AP-1. The anti-inflammatory activity of aspirin and sodium salicylate is related to blocking cyclooxygenase, especially COX-1, but the most important therapeutic potential of these drugs relies on the inhibition of IKK kinase-beta essential for activation of NF-B and its translocation to the nucleus [181, 182] . The anti-cytokine activity of various low-molecular mass drugs, such as cyclosporine, pentoxifylline, tenidap and some others have been discussed by many authors [169, 171] . However, special attention is due to a cyclic peptide cSN50 which contains a cell-permeable motif and nuclear localization sequence for a subunit of NF-B and was first described by Hawiger et al. [183] . The authors demonstrated anti-inflammatory potential of this construct in mice challenged with endotoxin [183] . Equally important may be a series of p38 MAP kinase inhibitors, that modulate cytokine mRNA stability and influence gene expression, cell proliferation and programmed cell death [94, 184] .
Natural and recombinant preparations of macromolecular inhibitors of pro-inflammatory cytokines include antiinflammatory cytokines (IL-4, IL-13, IL-10), IL-1 receptor antagonist, soluble receptors of TNF , IL-1 or gp130 (reviewed in [169] ), suppressors of cytokine signaling, especially SOCS3 (for references see [185] ), as well as various "tailored" preparations of TNF receptor or monoclonal antibodies against TNF and other pro-inflammatory cytokines (extensively reviewed by Tracey et al. [186) ]. Currently available are three TNF antagonists: adalimumab, human monoclonal antibody; etanercept, a soluble receptor construct; and infliximab, a chimeric monoclonal antibody, but several other preparations are under clinical trials [186] . Moreover, various "designer cytokines" represent new therapeutic tools intended for use in the prevention or treatment of chronic inflammation and cancer [81] .
Recently, TLRs are becoming important for therapeutical applications. Thanks to the studies of Akira and co-workers [187] we know that some low molecular mass antiviral drugs activate the immune system acting as agonists of TLR-7. On the other hand, Ishihara et al. [188] described attempts of therapeutic targeting of Toll-like receptors in gastrointestinal inflammation since soluble forms of TLR-4 and TLR-2 provide negative regulatory mechanisms in the inflammatory processes. As emphasized by Beutler and his group [189] we may either stimulate TLR signaling in order to eradicate specific infections or neoplastic disease, or block TLR signaling to treat inflammation.
THE ACUTE PHASE RESPONSE AND INNATE IMMUNITY -TWO SIDES OF A COIN
In many aspects the phenomenon of acute phase response resembles the first stages of an immunological reaction. On close scrutiny, when the molecular mechanisms are analyzed, one is tempted to conclude that we are dealing with two sides of a single biological process: the APR being studied mainly by biochemists, whereas the innate immunityby immunologists and clinicians. It is high time to combine research efforts of all groups of scientists involved to unravel the remaining mysteries of acute phase response / innate immunity, a fundamental biological phenomenon supporting our survival and health in the challenging environment.
To conclude, I would like to quote Yoo and Desiderio from a PNAS paper published in 2003 [27] :
"Recognition of stereotypic chemical patterns by sentinel cells of the innate immune system provokes a transient deviation from homeostasis, the acute phase response (APR). Although APR effectors have been identified individually, the complexity of the response suggested that emergent properties would be uncovered by a more comprehensive examination". If this is true then it is justified to say that "innate and acquired immunity intersect in a global view of the acute phase response".
